Platelet Toll-Like Receptor Expression: The Link Between “Danger” Ligands and Inflammation

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 5, 2010-12 ,pp. : 322-333

Bentham Science Publishers

Access to resources Recommend Favorite

The Toll of Toll-Like Receptors, Especially Toll-Like Receptor 2, on Murine Atherosclerosis

By  

Current Drug Targets, Vol. 8, Iss. 12, 2007-12 ,pp. : 1230-1238

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of Toll-like Receptor 2 and Toll-like Receptor 4 in Tuberculous Pleural Effusion

By  

Medicinal Chemistry, Vol. 13, Iss. 6, 2017-08 ,pp. : 569-576

Bentham Science Publishers

Access to resources Recommend Favorite

Aminobisphosphonates and Toll-Like Receptor Ligands: Recruiting V&ggr;9Vδ2 T Cells for the Treatment of Hematologic Malignancy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 34, 2011-12 ,pp. : 5206-5216

Bentham Science Publishers

Access to resources Recommend Favorite

Specific loss of Toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice

By Hasu Mirela   Thabet Mohamed   Tam Nancy   Whitman Stewart C.  

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 10, 2011-10 ,pp. : 737-742

NRC Research Press

Access to resources Recommend Favorite